The endless possibilities of 3D bioprinting: an interview with CELLINK

In this interview, CELLINK co-founders Erik Gatenholm and Héctor Martínez discuss the challenges and future potential of 3D bioprinting. In this interview, CELLINK (Sweden) co-founders Erik Gatenholm and Héctor Martínez discuss the challenges and future potential of 3D bioprinting for drug discovery and organ transplant. Erik Gatenholm (left) Erik Gatenholm, CEO and co-founder of CELLINK, studied management at Virginia Tech (VA, USA) and received his MSc in Innovation & Industrial Management from the University of Gothenburg (Sweden). He was previously founder of BC Genesis, a bio-medical device company focusing on the development of tissue reinforcement devices, such as surgical meshes...